This daily medication captures the same GLP-1 science in a convenient tablet form, providing a viable alternative for many patients in Birmingham
PlexusDx recommends a collaborative approach: regular check-ins with your precision health clinician, open communication with your mental health provider if you have one, and lifestyle strategies that support emotional wellbeing (sleep, movement, social connection, stress management)
Alternatively, cut a fresh lemon and hold it near your face
Never allow the needle or cartridge contact surfaces to touch non-sterile items
Key Phase 3 trials include: TRIUMPH-1: Retatrutide for obesity without type 2 diabetes TRIUMPH-2: Retatrutide for type 2 diabetes TRIUMPH-3: Retatrutide for obesity with type 2 diabetes TRIUMPH-4: Retatrutide for metabolic dysfunction-associated steatohepatitis (MASH) Results from these trials are expected between 2025 and 2027
Gastrointestinal side effects like nausea and diarrhea, and some sensory symptoms like tingling, were the most common